J. Piao

发表

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

D. Parsons, N. Ramirez, T. Alonzo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)

T. Merchant, C. Rodríguez-Galindo, M. Chintagumpala, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

C. Rodríguez-Galindo, G. Tiao, S. Ranganathan, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

J. O'Brien, K. Matthay, M. Ali, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group.

T. Alonzo, Lingyun Ji, J. Kairalla, 2019, JCO precision oncology.

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.

Michelle M. Nuño, A. L. Frazier, N. Coleman, 2021, Clinical genitourinary cancer.

The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database

Yukichi Tanaka, T. Hishiki, R. Alaggio, 2020, Pediatric blood & cancer.

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

N. Ramirez, T. Alonzo, M. Mooney, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

T. Alonzo, M. Mooney, D. Hawkins, 2021 .

Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial.

J. Gastier-Foster, T. Alonzo, M. Mooney, 2019, Journal of Clinical Oncology.

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee.

C. Weldon, G. Tiao, S. Ranganathan, 2020, Journal of pediatric surgery.

Doxorubicin in combination with cisplatin, 5‐flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study

C. Weldon, C. Rodríguez-Galindo, G. Tiao, 2021, Cancer.

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range

Michelle M. Nuño, V. Margulis, N. Coleman, 2023, Research square.

Vincristine/irinotecan/temsirolimus upfront window treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee

C. Weldon, C. Rodríguez-Galindo, S. Ranganathan, 2023, Pediatric blood & cancer.

Children's Oncology Group's 2023 blueprint for research: Rare tumors

M. Chintagumpala, T. Laetsch, E. Christison-Lagay, 2023, Pediatric blood & cancer.

A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)

C. Shields, J. O'Brien, D. Gombos, 2020, Pediatric blood & cancer.

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

T. Alonzo, M. Mooney, D. Hawkins, 2023, Journal of Clinical Oncology.

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

T. Alonzo, M. Mooney, D. Hawkins, 2023, Journal of Clinical Oncology.

Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C.

N. Ramirez, M. Mooney, D. Hawkins, 2023, Journal of the National Cancer Institute.

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

T. Alonzo, M. Mooney, D. Hawkins, 2022, Journal of Clinical Oncology.

Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's oncology group trial, AHEP0731.

C. Weldon, C. Rodríguez-Galindo, G. Tiao, 2022, Journal of pediatric surgery.

Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.

D. Hawkins, C. Rodríguez-Galindo, M. Chintagumpala, 2023, EJC paediatric oncology.

Imaging Appearance Of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign From Malignant Histology.

J. Ross, M. Krailo, D. Billmire, 2020, Journal of pediatric and adolescent gynecology.

Refining the serum miR-371a-3p test for viable germ cell tumor detection

Michelle M. Nuño, V. Margulis, A. L. Frazier, 2023, Scientific reports.